Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v2-FR
Language French French
Date Updated 2017-05-29 2017-03-14
Drug Identification Number 02326817 02326817
Brand name AMLODIPINE AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10.0MG 10.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-14 2017-03-14
Estimated end date 2017-06-30
Actual end date 2017-05-24
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments